Skip to main content

Bellevue Group AG

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1674546 Zurich, V8

Position in RARE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$66,204,857
+$16,343,857 QoQ
Shares Held
1,982,775
-16.7% QoQ
Ownership
2.01%
of shares outstanding
% of Portfolio
1.43%
of 13F equity value
Holder Rank
#12
of 311 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. RARE ranks #18 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RARE

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $66,204,857 1,982,775
2026-03-31 $49,861,000 2,380,000
2025-12-31 $59,340 2,580
2024-12-31 $168,280 4,000
2024-09-30 $222,200 4,000
2024-06-30 $164,400 4,000
2022-06-30 $1,849,460 31,000
2022-03-31 $1,866,334 25,700
2021-12-31 $1,765,890 21,000
2021-09-30 $2,516,301 27,900
2021-06-30 $2,040,490 21,400
2021-03-31 $4,668,260 41,000
2020-12-31 $5,675,630 41,000
2020-09-30 $3,369,790 41,000
2020-06-30 $1,877,280 24,000
2020-03-31 $955,245 21,500